We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+6.16%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$25B
AUM Growth
+$2.37B
Cap. Flow
+$1.17B
Cap. Flow %
4.67%
Top 10 Hldgs %
16.34%
Holding
2,152
New
227
Increased
430
Reduced
632
Closed
714

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$804M
2
ACN icon
Accenture
ACN
+$118M
3
SYY icon
Sysco
SYY
+$76.9M
4
AAPL icon
Apple
AAPL
+$76.7M
5
NTAP icon
NetApp
NTAP
+$69.1M

Sector Composition

Rank Sector Weight
1 Technology 16.58%
2 Healthcare 13.03%
3 Financials 12.46%
4 Consumer Discretionary 10.73%
5 Industrials 9.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HDV
526
iShares Core High Dividend ETF
HDV
$14.6B
$2.52M 0.01%
+138,955
New +$2.46M
MEI icon
527
Methode Electronics
MEI
$528M
$2.51M 0.01%
69,451
+70
+0.1% +$2.74K
WMB icon
528
Williams Companies
WMB
$87.5B
$2.46M 0.01%
90,671
+57,278
+172% +$1.66M
SUI icon
529
Sun Communities
SUI
$15.1B
$2.42M 0.01%
+23,800
New +$2.38M
CAJ
530
DELISTED
Canon, Inc.
CAJ
$2.37M 0.01%
75,020
-112,648
-60% -$3.57M
COR icon
531
Cencora
COR
$61B
$2.36M 0.01%
25,630
-10,404
-29% -$900K
QVCGA
532
DELISTED
QVC Group Inc Series A
QVCGA
$2.36M 0.01%
2,190
-1,724
-44% -$1.81M
ENR icon
533
Energizer
ENR
$1.44B
$2.35M 0.01%
40,169
+22,376
+126% +$1.41M
TOL icon
534
Toll Brothers
TOL
$14.1B
$2.34M 0.01%
70,941
-4,677
-6% -$169K
RRC icon
535
Range Resources
RRC
$8.98B
$2.31M 0.01%
136,287
+132,487
+3,487% +$2.13M
FUN icon
536
Cedar Fair
FUN
$1.77B
$2.31M 0.01%
44,357
XLV icon
537
State Street Health Care Select Sector SPDR ETF
XLV
$42.4B
$2.3M 0.01%
24,228
+1,115
+5% +$101K
ALSN icon
538
Allison Transmission
ALSN
$9.98B
$2.25M 0.01%
43,341
+36,562
+539% +$1.71M
DT
539
DELISTED
DEUTSCHE TELEKOM AG ADS (1ORD)
DT
$2.25M 0.01%
+139,732
New +$2.25M
SO icon
540
Southern Company
SO
$109B
$2.23M 0.01%
51,068
-7,098
-12% -$327K
PARA
541
DELISTED
Paramount Global Class B
PARA
$2.19M 0.01%
38,061
+36,124
+1,865% +$1.99M
WES icon
542
Western Midstream Partners
WES
$19.4B
$2.19M 0.01%
72,996
+6,864
+10% +$241K
SHLX
543
DELISTED
Shell Midstream Partners, L.P.
SHLX
$2.16M 0.01%
100,853
-1,592
-2% -$35.9K
BWA icon
544
BorgWarner
BWA
$13B
$2.14M 0.01%
56,919
-7,715
-12% -$303K
ROK icon
545
Rockwell Automation
ROK
$51.1B
$2.1M 0.01%
11,205
-105
-0.9% -$18.8K
Y
546
DELISTED
Alleghany Corp
Y
$2.08M 0.01%
3,183
-82
-3% -$51.3K
FTNT icon
547
Fortinet
FTNT
$112B
$2.07M 0.01%
112,175
-335,230
-75% -$5.13M
PAGP icon
548
Plains GP Holdings
PAGP
$5.18B
$2.05M 0.01%
83,704
+32,297
+63% +$800K
XLY icon
549
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$21.5B
$2.05M 0.01%
34,912
-5,004
-13% -$285K
PVH icon
550
PVH
PVH
$3.82B
$2.04M 0.01%
14,137
-1,779
-11% -$263K

Similar funds

Glenmede Trust's Q3 2018 Portfolio in Review

As of Q3 2018, Glenmede Trust held 2,152 positions worth $25B, up 11% from $22.6B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Glenmede Trust deployed $1.17B of net new capital in Q3 2018, opening 227 new positions and adding to 430 existing holdings. Its largest new stake was Vanguard Small-Cap ETF: 518,651 shares worth $84.3M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Johnson & Johnson, an estimated $804M trimmed.

  • Glenmede Trust's largest Q3 2018 buy was Vanguard Small-Cap ETF: 518,651 shares worth $84.3M.
  • Glenmede Trust added most to Alphabet (Google) Class A in Q3 2018, an estimated $783M increase.
  • Glenmede Trust's biggest Q3 2018 reduction was Johnson & Johnson, cutting an estimated $804M.
  • Glenmede Trust fully exited BioTelemetry, Inc. in Q3 2018, selling an estimated $43.4M.
  • Glenmede Trust's ten largest holdings make up 16% of its $25B portfolio in Q3 2018.
  • Glenmede Trust opened 227 new positions and closed 714 in Q3 2018.
  • Glenmede Trust's portfolio value rose 11% quarter-over-quarter to $25B.

Based on Glenmede Trust's 13F filing for Q3 2018, filed 15 Nov 2018.